Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF.
about
Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?Diagnostics for pulmonary tuberculosisImpact of Molecular Diagnostics for Tuberculosis on Patient-Important Outcomes: A Systematic Review of Study MethodologiesRole of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus InfectionMicrobiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment InitiationTreating the invisible: Gaps and opportunities for enhanced TB control along the Thailand-Myanmar borderThe effect of the Xpert MTB/RIF test on the time to MDR-TB treatment initiation in a rural setting: a cohort study in South Africa’s Eastern Cape ProvinceWhat happens after a negative test for tuberculosis? Evaluating adherence to TB diagnostic algorithms in South African Primary Health Clinics.Tuberculosis innovations mean little if they cannot save livesCost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation.Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert™ MTB/RIF era: a cohort study.Sputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda.Implementation of the Xpert MTB/RIF assay for tuberculosis in Mongolia: a qualitative exploration of barriers and enablersEvaluation of a point-of-care tuberculosis test-and-treat algorithm on early mortality in people with HIV accessing antiretroviral therapy (TB Fast Track study): study protocol for a cluster randomised controlled trial.Missed Opportunities for TB Investigation in Primary Care Clinics in South Africa: Experience from the XTEND Trial.Diagnostic Accuracy of the Small Membrane Filtration Method for Diagnosis of Pulmonary Tuberculosis in a High-HIV-Prevalence Setting.Wide Variations in Compliance with Tuberculosis Screening Guidelines and Tuberculosis Incidence between Antiretroviral Therapy Facilities - Côte d'Ivoire.Xpert MTB/RIF - why the lack of morbidity and mortality impact in intervention trials?The Epidemiology of Meningitis among Adults in a South African Province with a High HIV Prevalence, 2009-2012Implementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana's Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early antiretroviral therapy mortality.Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program.Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study.Assessing the utility of Xpert(®) MTB/RIF as a screening tool for patients admitted to medical wards in South Africa.Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?Implementation and Operational Research: What Happens After a Negative Test for Tuberculosis? Evaluating Adherence to TB Diagnostic Algorithms in South African Primary Health Clinics.Implementation of Xpert MTB/RIF in Uganda: Missed Opportunities to Improve Diagnosis of Tuberculosis.Mixed impact of Xpert(®) MTB/RIF on tuberculosis diagnosis in CambodiaEmpirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trialTuberculosis screening in patients with HIV: use of audit and feedback to improve quality of care in Ghana.Incorporating Demand and Supply Constraints into Economic Evaluations in Low-Income and Middle-Income CountriesUsing Top-down and Bottom-up Costing Approaches in LMICs: The Case for Using Both to Assess the Incremental Costs of New Technologies at ScaleVerbal autopsy-assigned causes of death among adults being investigated for TB in South Africa.Cost-effectiveness of triage testing for facility-based systematic screening of tuberculosis among Ugandan adults.A Proposed Framework for the Implementation of Early Infant Diagnosis Point-of-CareAccess and Quality of HIV-Related Point-of-Care Diagnostic Testing in Global Health Programs.The impact of the roll-out of rapid molecular diagnostic testing for tuberculosis on empirical treatment in Cape Town, South AfricaRolling Out Xpert® MTB/RIF for TB Detection in HIV-Infected Populations:An Opportunity for Systems StrengtheningThe paradigm shift to end tuberculosis. Are we ready to assume the changes?Diagnosis of Tuberculosis in HIV Co-infected Individuals: Current Status, Challenges and Opportunities for the Future.The development, evaluation and performance of molecular diagnostics for detection of Mycobacterium tuberculosis.
P2860
Q26740240-3E073D32-39AB-4A15-9B8E-D12943186AC7Q26752633-069C6635-CED3-4708-9B72-CBD8C37D2D8DQ26767271-D02588CA-78BD-44F8-AF89-4B1D460EDE0FQ26776408-D23B8F72-CEEA-4D89-8B54-896331343C67Q28469353-1232F198-4FC4-4E35-A492-0E6913DBE6FBQ28563994-F474DF60-E985-480D-9B01-66DE6ECD0405Q29247880-76508B66-5E1A-421A-B9DE-7E862F2C5EF8Q30488634-70265BB1-B6AF-4406-82E0-CA6D513FD903Q33627409-A9BDF870-2419-4E5C-810A-F6A70774B220Q33800939-F4EB6EDF-4A0C-4858-BC14-32D4D82AE005Q33808388-0E327DAA-7EFA-4AB3-A2F0-04F701BCA291Q33884141-F5476A5C-C1C6-4B32-A318-3B540F3C9D3AQ33906816-035340E9-614E-440E-838A-D19C33C6CC18Q35382585-FBE12168-F52E-47F6-8DD3-8FA5E62FBE78Q35780201-A669751C-1B15-4511-8324-56861D2A5CB7Q35974728-98ECA6B5-BE49-4795-9567-9E1E12F2DA59Q36044825-89D6A73C-3A03-44EE-AE8F-DB7FE30EF988Q36136013-7A3DF261-9AE8-4530-AE4E-89579665E495Q36145111-DD58E7D3-7719-4D3D-B581-28F847886A40Q36174697-4F48D38B-145D-4D64-AEF9-A9021738EF25Q36275494-4D0BDF8C-B7B5-4D72-B150-C0C16B1E4C58Q36286134-202C3216-9ED8-446D-A4C0-08633FB8E1B4Q36501101-CE64A5CE-4B97-40EB-BE3A-342AACBBFF05Q36715814-21AB28BF-4101-4D4E-8A80-BE73D451D001Q36721007-5B927A99-B3D2-40F7-8014-FEE2C2617CF5Q36899978-9F068FDF-0139-425E-9FB4-3A5D8C99462BQ37020517-ECE2EC28-AE77-40ED-ABD8-6E5156355931Q37061089-026F9DF5-FD8D-4D52-A65E-B92BCCF8CA17Q37212402-2A544419-45A7-4912-856F-0B8A24037F18Q37295972-23C9833D-5E9D-490A-9693-3E45E9A40AF5Q37343926-E4BD6E3D-A332-4F37-88B0-1EA560E158D3Q37387998-3BD8CFD8-5FFB-4ABC-8615-514EA2A011F0Q37659683-5AE2D746-9A9D-4D57-ACCB-CD9B5165C3C6Q37677001-12829D31-239F-4F72-B582-A5F89951B57EQ38386355-6C98309A-F753-412D-943D-02F9E5D4AB3DQ38399097-D4A1BE24-093A-450F-B034-39BC96F0443EQ38645708-BB72798F-A9DA-4E8E-84EA-9B64F40F3DFBQ38676708-E268F80C-CAB1-42C1-96CC-EF913EB29AF1Q38682808-068C5169-C68E-4EBC-AE08-4DD026FD78ADQ38688148-4E009AA8-56DC-4246-A67B-3FC141B38B9B
P2860
Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Xpert MTB/RIF versus sputum mi ...... can roll-out of Xpert MTB/RIF.
@en
type
label
Xpert MTB/RIF versus sputum mi ...... can roll-out of Xpert MTB/RIF.
@en
prefLabel
Xpert MTB/RIF versus sputum mi ...... can roll-out of Xpert MTB/RIF.
@en
P2093
P50
P921
P1476
Xpert MTB/RIF versus sputum mi ...... can roll-out of Xpert MTB/RIF.
@en
P2093
Alison D Grant
Edina Sinanovic
Lerole D Mametja
Linda K Erasmus
Lindiwe Mvusi
Norbert O Ndjeka
Wendy S Stevens
P304
P356
10.1016/S2214-109X(15)00100-X
P50
P577
2015-08-01T00:00:00Z